Nobel Biocare appoints new president

Nobel Biocare has announced that Hans Geiselhöringer has taken the reins as president of the company.

Nobel Biocare has announced that, as of January 1, Hans Geiselhöringer has taken over as President of Nobel Biocare. In a press release, the company said the appointment was made to strengthen the organization around its strategic goals.

Since 2011, Hans Geiselhöringer has served as Executive Vice President of Global Research, Products and Development, shaping Nobel Biocare’s product and innovation pipeline. Prior to that, he was Executive Vice President Global Marketing and Products from 2010–2011 and Head of NobelProcera and Guided Surgery from 2009–2010. Hans joined Nobel Biocare as Head of NobelProcera in 2008 and was appointed a member of the executive committee in 2009.

Related reading: Nobel Biocare's cement-free solution

From 2004 to 2009, Hans acted as a Global Speaker for Nobel Biocare and with this appointment, he becomes the first Nobel Biocare customer and dental expert in the company’s history to take the reigns as its highest ranking executive.

In 1998, he founded DentalX GmbH, a dental laboratory chain specializing in implantology, anaplastology, functional and esthetic reconstructions and imaging technologies. Hans is a trained Dental Technician and possesses great technical knowledge of the implant and CAD/CAM industries, as well as deep customer understanding and insights. He has published/co-published various clinical and research articles, and is also a member of numerous international dental associations and a recognized lecturer at dental conventions throughout the world.

10 Questions: The innovations of Nobel Biocare

In a statement, Geiselhöringer said: “Our focus on the patient remains steadfast and constant. Everything we do will continue to be patient-centered, clinically relevant and evidence based. To strengthen our leadership in implant-based dentistry we strongly focus on providing integrated digital solutions to improve the customer experience and increase productivity on all levels while ensuring a high level of clinical success and predictability. With our counterparts at KaVo Kerr Group, we have all the pieces in place today and we are grouping our highly skilled global teams together to form the industry’s new digital dentistry powerhouse. In summary, we at Nobel Biocare will continue our strong commitment to innovation, providing an ongoing pipeline of superior solutions that helps more customers treat more patients better.”